Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helen Parker

Showing results (51-60 of 81) with videos related to

Pageof 9
Sort By:
Neuro-Oncology|April 1, 2020
Actinomycin D downregulates Sox2 and improves survival in preclinical models of recurrent glioblastomaJessica T Taylor, Stuart Ellison, Alina Pandele, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 30, 2008
Variable breakpoints target PAX5 in patients with dicentric chromosomes: a model for the basis of unbalanced translocations in cancerQian An, Sarah L Wright, Zoë J Konn, et al.
Genes, Chromosomes & Cancer|September 4, 2008
The complex genomic profile of ETV6-RUNX1 positive acute lymphoblastic leukemia highlights a recurrent deletion of TBL1XR1Helen Parker, Qian An, Kerry Barber, et al.
Blood|April 30, 2011
Genomic characterization implicates iAMP21 as a likely primary genetic event in childhood B-cell precursor acute lymphoblastic leukemiaVikki Rand, Helen Parker, Lisa J Russell, et al.
Human Gene Therapy|April 26, 2019
An Improved Adeno-Associated Virus Vector for Neurological Correction of the Mouse Model of Mucopolysaccharidosis IIIAAnna L Gray, Claire O'Leary, Aiyin Liao, et al.
Blood|October 23, 2012
The clinical significance of NOTCH1 and SF3B1 mutations in the UK LRF CLL4 trialDavid G Oscier, Matthew J J Rose-Zerilli, Nils Winkelmann, et al.
Journal of Inherited Metabolic Disease|May 28, 2021
High dose genistein in Sanfilippo syndrome: A randomised controlled trialArunabha Ghosh, Stewart Rust, Kia Langford-Smith, et al.
Molecular Therapy. Methods & Clinical Development|May 3, 2019
Pre-clinical Safety and Efficacy of Lentiviral Vector-Mediated <i>Ex Vivo</i> Stem Cell Gene Therapy for the Treatment of Mucopolysaccharidosis IIIAStuart M Ellison, Aiyin Liao, Shaun Wood, et al.
Molecular Metabolism|April 2, 2015
LKB1 and AMPKα1 are required in pancreatic alpha cells for the normal regulation of glucagon secretion and responses to hypoglycemiaGao Sun, Gabriela da Silva Xavier, Tracy Gorman, et al.
Haematologica|March 4, 2014
ATM mutation rather than BIRC3 deletion and/or mutation predicts reduced survival in 11q-deleted chronic lymphocytic leukemia: data from the UK LRF CLL4 trialMatthew J J Rose-Zerilli, Jade Forster, Helen Parker, et al.
Pageof 9

Showing results (51-60 of 81) with videos related to

Sort By:
Pageof 9
Neuro-Oncology|April 1, 2020
Actinomycin D downregulates Sox2 and improves survival in preclinical models of recurrent glioblastomaJessica T Taylor, Stuart Ellison, Alina Pandele, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 30, 2008
Variable breakpoints target PAX5 in patients with dicentric chromosomes: a model for the basis of unbalanced translocations in cancerQian An, Sarah L Wright, Zoë J Konn, et al.
Genes, Chromosomes & Cancer|September 4, 2008
The complex genomic profile of ETV6-RUNX1 positive acute lymphoblastic leukemia highlights a recurrent deletion of TBL1XR1Helen Parker, Qian An, Kerry Barber, et al.
Blood|April 30, 2011
Genomic characterization implicates iAMP21 as a likely primary genetic event in childhood B-cell precursor acute lymphoblastic leukemiaVikki Rand, Helen Parker, Lisa J Russell, et al.
Human Gene Therapy|April 26, 2019
An Improved Adeno-Associated Virus Vector for Neurological Correction of the Mouse Model of Mucopolysaccharidosis IIIAAnna L Gray, Claire O'Leary, Aiyin Liao, et al.
Blood|October 23, 2012
The clinical significance of NOTCH1 and SF3B1 mutations in the UK LRF CLL4 trialDavid G Oscier, Matthew J J Rose-Zerilli, Nils Winkelmann, et al.
Journal of Inherited Metabolic Disease|May 28, 2021
High dose genistein in Sanfilippo syndrome: A randomised controlled trialArunabha Ghosh, Stewart Rust, Kia Langford-Smith, et al.
Molecular Therapy. Methods & Clinical Development|May 3, 2019
Pre-clinical Safety and Efficacy of Lentiviral Vector-Mediated <i>Ex Vivo</i> Stem Cell Gene Therapy for the Treatment of Mucopolysaccharidosis IIIAStuart M Ellison, Aiyin Liao, Shaun Wood, et al.
Molecular Metabolism|April 2, 2015
LKB1 and AMPKα1 are required in pancreatic alpha cells for the normal regulation of glucagon secretion and responses to hypoglycemiaGao Sun, Gabriela da Silva Xavier, Tracy Gorman, et al.
Haematologica|March 4, 2014
ATM mutation rather than BIRC3 deletion and/or mutation predicts reduced survival in 11q-deleted chronic lymphocytic leukemia: data from the UK LRF CLL4 trialMatthew J J Rose-Zerilli, Jade Forster, Helen Parker, et al.
Pageof 9